By correlating ITSS with a comprehensive panel of molecular alterations (including IDH mutation, 1p/19q co-deletion, and CDKN2A/B homozygous deletion), our findings demonstrate the relevance of semiquantitative ITSS grading in the current era of molecularly driven glioma characterization. This evidence concerns the gene IDH1 and central nervous system cancer.